Boehringer Ingelheim Pharmaceuticals, Inc.

Ridgefield, Connecticut 06879

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, HIV Infections, Lung Diseases, Interstitial

Studies at this site

• Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease — Completed
• Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment — Completed
• Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas — Withdrawn before enrolling
• An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease — Completed